Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1991-7-8
pubmed:abstractText
The cytokine interleukin-6, which has been shown to be increased in patients with burn injuries, is produced by activated monocytes and endothelial cells and has many in vitro activities, including stimulation of acute-phase protein synthesis in hepatocytes, immunoglobulin synthesis in B lymphocytes, and stimulation of growth of megakaryocytes. In 13 patients with a mean of 31% full-thickness burns, we studied the relation of serum interleukin-6 to clinical parameters and parameters of the acute-phase response and immunoglobulin production. Interleukin-6 was already elevated within hours after the injury was sustained, and it remained elevated for several weeks. All components of the acute-phase response were observed: fever, tachycardia, leukocytosis with an associated left shift, elevation of C-reactive protein and alpha 1-antitrypsin, and a decrease in albumin levels. In the second week after burn injury, immunoglobulin M levels peaked, followed by a prolonged elevation of immunoglobulin G levels. Thrombocyte counts initially decreased and rebounded to supranormal levels after 2 weeks. Interleukin-6 levels were positively correlated with acute-phase responses. We believe that the production of interleukin-6 induces the synthesis of acute-phase proteins. High interleukin-6 levels may also be an etiologic factor in the marked immunoglobulin response observed. Likewise, the relation between the megakaryocyte-promoting activity of interleukin-6 and the rebound thrombocytosis requires further investigation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0039-6060
pubmed:author
pubmed:issnType
Print
pubmed:volume
109
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
761-7
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:2042096-Adult, pubmed-meshheading:2042096-Antibody Formation, pubmed-meshheading:2042096-Biological Markers, pubmed-meshheading:2042096-Blood Proteins, pubmed-meshheading:2042096-Body Temperature, pubmed-meshheading:2042096-Burns, pubmed-meshheading:2042096-C-Reactive Protein, pubmed-meshheading:2042096-Complement Activation, pubmed-meshheading:2042096-Complement C4, pubmed-meshheading:2042096-Complement System Proteins, pubmed-meshheading:2042096-Female, pubmed-meshheading:2042096-Heart Rate, pubmed-meshheading:2042096-Hemoglobins, pubmed-meshheading:2042096-Humans, pubmed-meshheading:2042096-Immunoglobulin G, pubmed-meshheading:2042096-Immunoglobulin M, pubmed-meshheading:2042096-Interleukin-6, pubmed-meshheading:2042096-Leukocyte Count, pubmed-meshheading:2042096-Male, pubmed-meshheading:2042096-Models, Biological, pubmed-meshheading:2042096-Platelet Count, pubmed-meshheading:2042096-Time Factors, pubmed-meshheading:2042096-alpha 1-Antitrypsin
pubmed:year
1991
pubmed:articleTitle
Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients.
pubmed:affiliation
Central Laboratory, The Netherlands Red Cross Blood Transfusion Service, Groningen.
pubmed:publicationType
Journal Article